TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EVE Health Group Limited ( (AU:EVE) ) has provided an announcement.
EVE Health Group Limited has signed a Patient Support Telehealth Services Agreement with hubMed Pty Ltd to enhance care for patients using EVE’s products for women’s and men’s health conditions. This partnership aims to improve continuity of care through regular telehealth consultations, supporting patient adherence and timely clinical guidance. The initiative is expected to strengthen EVE’s market positioning by providing better patient outcomes and expanding their digital ecosystem to support product launches.
More about EVE Health Group Limited
EVE Health Group Limited is a company operating in the healthcare industry, focusing on therapeutic products for women’s and men’s health. Their primary products include Dyspro™ for dysmenorrhoea and Libbo™ for erectile dysfunction, with a market focus on addressing significant unmet needs in these areas.
Average Trading Volume: 667,860
Technical Sentiment Signal: Sell
Current Market Cap: A$7.92M
Learn more about EVE stock on TipRanks’ Stock Analysis page.